Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Theakine Cardio
- Development stage
- Preclinical
- Lead developer
- Adamas Biotech
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Theakine Cardio is a pharmaceutical-grade nutraceutical product under development by Adamas Biotech, an Italian biotechnology firm controlled by Cube Labs. It is specifically formulated with standardized green tea extract (GTE), containing high concentrations of catechins such as epigallocatechin gallate (EGCG), which are known for their potent antioxidant properties. The product is designed to support athletic endurance and enhance cardiovascular and metabolic performance in active individuals by strengthening the body's natural antioxidant defense system and mitigating oxidative stress induced by physical activity. Currently in the preclinical stage, Theakine Cardio utilizes high-purity extracts like Theaphenon E to ensure standardized delivery of active polyphenols.
- Brand names
- Theakine Cardio
- Other names
- Theakine® Cardio
02
Targets
JAK2 (Janus kinase 2)STAT3 (Signal Transducer and Activator of Transcription 3)AMPK (Adenosine monophosphate–activated protein kinase)PPARA (Peroxisome proliferator-activated receptor alpha)NF-κBERKNOS3 (eNOS)PPARG (Peroxisome proliferator-activated receptor gamma)BAX (Apoptosis regulator BAX)SREBP-1 / SREBF1 (SREBP-1)NFE2L2 (Nuclear factor (erythroid-derived 2)-like 2)
Beyond the preview
Go deeper on Theakine Cardio.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Theakine Cardio.